Genetics of lipodystrophy syndromes

Area of Science:

• Genetics
• Endocrinology
• Metabolic Disorders

Background:

• Lipodystrophic syndromes (LS) are a diverse group of disorders marked by adipose tissue loss and significant metabolic complications.
• Classical LS forms (partial, generalized, progeroid) often stem from genetic defects in adipogenesis and adipocyte function.
• Emerging research identifies complex systemic disorders with lipodystrophy, autoinflammation, and organ dysfunction.

Purpose of the Study:

• To explore the genetic heterogeneity of lipodystrophic syndromes.
• To highlight the role of advanced genetic sequencing in identifying novel disease-causing genes.
• To emphasize the need for collaborative efforts in understanding LS pathophysiology and advancing personalized medicine.

Main Methods:

• Utilizing next-generation sequencing (NGS) approaches, including exome and whole-genome sequencing.
• Analyzing genetic data to identify potential disease-causing variants.
• Reviewing international recommendations for variant interpretation and classification.

Main Results:

• Over thirty genes are currently linked to monogenic LS, yet many cases remain genetically unexplained.
• NGS technologies accelerate the discovery of new genes associated with LS.
• Challenges persist in interpreting large-scale genetic data.

Conclusions:

• Continued genetic research is crucial for elucidating the molecular basis of LS.
• Collaboration among geneticists, clinicians, and researchers is essential for progress.
• Advancements in genetic analysis pave the way for personalized treatment strategies for lipodystrophy.